IV:
>10%:
Kardiovaskular: eksaserbasi dari angina pektoris (20%)
Sistem saraf pusat: dizziness (12%), sakit kepala (12%)
1-10%:
Kardiovaskular: hipotensi (5%), hipertensi(2%),
abnormalitas ECG (5-8%), nyeri (3%), takikardia (3%)
Sistem saraf pusat: kemerahan (3%), kelelahan (1%)
Gastrointestinal: mual (5%)
Respiratori: dyspnea (3%)
Monitoring:
Interaksi nimodipin + carbamazepin = monitoring tekanan
darah.
Interaksi nimodipin + beta-bloker = monitoring tekanan
darah, denyut jantung.
Interaksi nimodipin + golongan azole = monitoring
tekanan darah.
Interaksi nimodipin + penytoin = monitoring dosis.
Profil Farmakokinetika : 1. Absorbsi
Bioavailabilitas: 13%
Peak Plasma Time: 1 hr
Peak Plasma Concentration: 80 ng/mL
2. Distribusi
Protein Bound: 95%
Vd: 0.43 L/kg
3. Metabolisme
Hepatic P450 enzyme CYP3A4
4. Eliminasi
Half-Life: 1-2 hr
Total Body Clearance: 0.84 L/kg (healthy); 1.18 L/kg
(SAH)
Excretion: Urine (50%); feces (32%)